Inici › Trastorn depressiu major › Texas › Houston
Assaigs clínics de Trastorn depressiu major a Houston, TX
16 estudis de Trastorn depressiu major busquen participants en centres de Houston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
ReclutantFase 3
- Baylor College of Medicine, Houston
- Houston Clinical Trials LLC, Bellaire · a 7 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
ReclutantFase 3
- DM Clinical Research, Houston
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
ReclutantFase 3
- John S Dunn Behavioral Sciences Center at UTHealth Houston, Houston
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
ReclutantFase 3
- Brain Health Consultants and TMS Center, Houston
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
ReclutantFase 3
- Vanda Investigational Site, Houston
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
ReclutantFase 1Voluntaris sans benvinguts
- Wells Medicine, Houston
- Texas A&M (Houston Methodist Hospital Location), Houston
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
ReclutantFase 2
- Baylor College of Medicine, Houston
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Reclutant
- CHI St. Luke's Health Baylor College of Medicine Med. Ctr, Houston
- The Methodist Hospital, Houston
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
ReclutantFase 2
- Elevate Synapsis, LLC, Atascocita · a 20 mi
- Synapsis Bio, Atascocita · a 20 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutantFase 3
- Neurocrine Clinical Site, Bellaire · a 7 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutantFase 3
- Neurocrine Clinical Site, Houston
- Neurocrine Clinical Site, Bellaire · a 7 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
ReclutantFase 3
- Clinical Research Site, Houston
- Clinical Research Site, Bellaire · a 7 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
ReclutantFase 2
- Houston Clinical Trials - Bellaire /ID# 277551, Bellaire · a 7 mi
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
Reclutant
- Houston Center For Advanced Psychiatric Treatment, Houston
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutantFase 3
- Neurocrine Clinical Site, Houston
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
ReclutantVoluntaris sans benvinguts
- Michael E. DeBakey VA Medical Center, Houston
- The University of Texas health Science Center at Houston, Houston
Assaigs de Trastorn depressiu major en altres ciutats
- New York City, NY37 estudis
- Boston, MA31 estudis
- Atlanta, GA25 estudis
- Philadelphia, PA23 estudis
- Orlando, FL19 estudis
- Miami, FL18 estudis
- Tampa, FL17 estudis
- Chicago, IL17 estudis
- San Diego, CA16 estudis
- Little Rock, AR14 estudis
- Orange, CA13 estudis
- Austin, TX13 estudis
Altres estudis a Houston
- Càncer de pulmó de cèl·lules no petites145 estudis
- Càncer de mama126 estudis
- Càncer (tots els tipus)121 estudis
- Càncer metastàtic104 estudis
- Càncer colorrectal102 estudis
- Càncer d'ovari89 estudis
- Leucèmia mieloide aguda85 estudis
- Càncer de pulmó78 estudis
- Càncer de pròstata76 estudis
- Càncer d'endometri68 estudis
- Càncer de pàncrees61 estudis
- Melanoma59 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.